DMEPOS Supplier Accreditation FAQ — Your Questions Answered

Last updated: October 2026

Answers to questions about CMS DMEPOS supplier accreditation requirements, the 2026 rule changes, accreditor selection, process, costs, and risk — from IHS, a specialized healthcare accreditation consulting firm founded in 2002 by Thomas G. Goddard, JD, PhD, former URAC COO and General Counsel.

DMEPOS Accreditation Consulting Overview | ACHC vs. BOC vs. TCT Comparison | Cost Guide

What Is DMEPOS Accreditation?

What does DMEPOS stand for and what types of suppliers need accreditation?

DMEPOS stands for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Any organization billing Medicare for covered DMEPOS items — hospital beds, wheelchairs, respiratory equipment, diabetic testing supplies, orthotics, continuous glucose monitors (CGMs), enteral nutrition, and more — must hold active accreditation from a CMS-approved accrediting organization as a mandatory condition of Medicare enrollment.

The rule is broad: if your organization receives Medicare reimbursement for any item in the DMEPOS category, you need accreditation. This includes traditional HME/DME suppliers, pharmacies billing DMEPOS codes, O&P clinics, physical therapists providing OTS orthotics, dental sleep medicine practices, and retailers distributing DMEPOS products across state lines.

Is DMEPOS accreditation required for all suppliers or only those billing Medicare?

Accreditation is required only for suppliers billing Medicare for DMEPOS items — it is a condition of Medicare enrollment specifically. Private pay and Medicaid-only suppliers are not federally required to be accredited, though individual state Medicaid programs may impose their own accreditation requirements.

Which accreditation organizations are currently CMS-approved for DMEPOS?

CMS publishes a list of approved DMEPOS accreditation organizations. The list CMS updated on January 9, 2026 names eight (CMS, DMEPOS Accreditation Organizations and its list, pages opened October 6, 2026):

1. ACHC (Accreditation Commission for Health Care)
2. ABC (American Board for Certification in Orthotics, Prosthetics & Pedorthics)
3. CHAP (Community Health Accreditation Program)
4. HQAA (Healthcare Quality Association on Accreditation)
5. TJC (The Joint Commission)
6. NABP (National Association of Boards of Pharmacy)
7. The Compliance Team (TCT)
8. BOC (Board of Certification/Accreditation) — federal lawsuit filed December 2025 (Board of Certification/Accreditation International, Inc. v. Kennedy, No. 1:25-cv-04150 (D. Md.), docket, page opened October 4, 2026). Check BOC's current CMS status in your state

The CMS list shows NABP for Sections I and II and Appendix A, for part of Appendix C (external breast prostheses, therapeutic shoes and inserts, and their accessories and supplies), and not for Appendix B (manual wheelchairs, power mobility devices and complex rehabilitative wheelchairs and assistive technology). CMS tells a supplier seeking accreditation to contact the accreditation organizations directly. Verify the current list with CMS.

IHS has no financial relationship with any accrediting organization and helps each client weigh AO options against its own needs. See our ACHC vs. BOC vs. TCT Comparison for the detailed side-by-side analysis.

What are the CMS DMEPOS Supplier Quality Standards?

The CMS DMEPOS Supplier Quality Standards are the baseline federal requirements every Medicare-enrolled DMEPOS supplier must meet. They cover: supplier code of conduct, complaint handling processes, patient privacy and HIPAA, equipment cleaning and maintenance, delivery and setup requirements, employee training and competency verification, quality improvement programs, and emergency preparedness. Accrediting organizations verify compliance with these standards (plus their own supplemental requirements) through unannounced on-site surveys.

What is "deemed status" in the DMEPOS accreditation context?

Deemed status means CMS has determined that holding accreditation from a specific AO satisfies CMS's own verification requirements. Instead of CMS conducting its own separate inspection, the AO's accreditation decision is "deemed" sufficient. Deemed status is why accreditation from a CMS-approved AO is a legal condition of Medicare enrollment — it is CMS's delegated quality oversight mechanism for the DMEPOS supplier industry.

Who Needs DMEPOS Accreditation?

Do pharmacies need separate DMEPOS accreditation to bill for diabetic supplies or orthotics?

Yes — pharmacies billing Medicare for DMEPOS-covered products (diabetic testing supplies, enteral nutrition, off-the-shelf orthotics) must hold DMEPOS supplier accreditation. Standard pharmacy accreditation (URAC, ACHC pharmacy, NABP PCAB) does not cover DMEPOS billing by itself. NABP accreditation covers both pharmacy and certain DMEPOS billing categories in a single credential for qualifying pharmacies. ACHC's pharmacy division is another route.

Are home infusion therapy suppliers subject to DMEPOS accreditation rules?

Home infusion therapy has its own Medicare benefit category with separate billing and accreditation requirements under Section 5012 of the 21st Century Cures Act. However, suppliers billing for infusion pumps or certain enteral nutrition products that fall under DMEPOS codes must also hold DMEPOS supplier accreditation for those specific categories. IHS assesses both HIT and DMEPOS requirements in a combined gap analysis for suppliers with overlapping service lines.

What is the DMEPOS Competitive Bidding Program and does it add accreditation requirements?

The DMEPOS Competitive Bidding Program (CBP) is CMS's mechanism for setting Medicare reimbursement rates for select DMEPOS categories through a competitive bidding process. Round 2028 covers Class II CGMs and insulin pumps, urological and ostomy supplies, and off-the-shelf braces (CBIC, Product Categories, page opened October 3, 2026). CMS's competitive bidding contractor lists target dates for Round 2028 of the Competitive Bidding Program: bidder registration and the bid window in late fall 2026, contract awards in late summer or early fall 2027, and the start of Round 2028 no later than January 1, 2028 (CBIC, Round 2028 Timeline, page opened October 3, 2026). CMS can award a contract only to a bidder accredited by a CMS-approved accrediting organization for every item in each product category it bids on (CBIC, Bidder Eligibility Requirements, page opened October 3, 2026).

How Does the DMEPOS Accreditation Process Work?

What are the steps to get DMEPOS supplier accreditation?

Six phases from non-compliant to Medicare-enrolled:

1. Weeks 1–3: Gap Assessment — review operations and documentation against CMS Quality Standards and AO standards manual to identify vulnerabilities
2. Weeks 4–8: Policy and Procedure Development — customize required P&P for your specific product categories, including TB control plans, equipment cleaning protocols, complaint procedures, and corporate compliance frameworks
3. Weeks 9–12: Implementation and Training — train staff on HIPAA, FWA, OSHA, patient equipment instruction; generate compliant training documentation logs
4. Weeks 13–14: Mock Survey — unannounced simulated survey with staff interviews, facility inspection, and tracer exercises
5. Weeks 15–20+: Application and Live Survey — submit application and non-refundable deposit; AO dispatches unannounced surveyor
6. Weeks 20–30+: Plan of Correction and PECOS Enrollment — resolve any cited deficiencies; submit CMS-855S through PECOS for Medicare enrollment

What changed with the 2026 annual survey requirement and what does it mean operationally?

Effective January 1, 2026, CMS requires DMEPOS suppliers to be resurveyed at least once every 12 months. Previously, surveys occurred every 36 months. The operational shift is fundamental: ad hoc accreditation preparation every three years is no longer viable. Continuous readiness is now the operational standard — meaning ongoing documentation hygiene, regular internal audits, and continuous staff training. Organizations with more than $2 million in annual Medicare billing may need 0.5 to 1.0 dedicated FTE focused on QAPI.

What is a Corrective Action Plan (CAP) and what are the submission timelines?

A CAP (also called a Plan of Correction) is the formal written response submitted to the AO when a surveyor cites deficiencies during the on-site survey. The CAP must document: what specific corrective action was taken for each cited deficiency, who was responsible, and the completion date. AO-specific submission deadlines typically run 10 to 30 days from receipt of the deficiency report. ACHC provides a structured template; TCT manages CAP submissions through its real-time web portal. Failure to submit a timely, substantive CAP can result in accreditation denial and require a full re-survey.

What happened to the 90-day temporary billing grace period for new DMEPOS locations?

Eliminated. Effective January 1, 2026, every new DMEPOS physical location must be fully surveyed and accredited before billing a single Medicare claim. The 90-day temporary billing authorization that previously allowed new locations to begin billing while awaiting accreditation no longer exists. For multi-location operators or organizations planning expansion, this change requires building complete accreditation preparation into the pre-opening timeline — adding 4 to 8 months to new location launch planning. (Source: CMS DMEPOS Accreditation Guidance)

What is the CMS enrollment timeline after receiving DMEPOS accreditation?

After accreditation award, the supplier submits Form CMS-855S through PECOS (Provider Enrollment, Chain, and Ownership System). CMS's federal mandate is 50 calendar days for online PECOS processing (95th percentile) or 65 calendar days for paper CMS-855S submissions. IHS helps your team track PECOS application status and prepare follow-up when processing runs past standard timelines. Total time from engagement start to first Medicare claim: typically 6 to 14 months.

How Much Does DMEPOS Accreditation Cost?

How much does DMEPOS accreditation cost with ACHC vs. other accrediting bodies?

Fee structures vary by AO. ABC publishes a transparent 2026 schedule: first-time primary location $1,855 (includes application and on-site survey), affiliate locations $965 each (max 4), annual maintenance $630 primary / $315 affiliate, renewal $1,225. ACHC and TCT use custom quoting — contact them directly for current pricing. CMS's published 2026 enrollment application fee is $750; generally institutional providers and suppliers such as DMEPOS suppliers pay it when enrolling, re-enrolling, revalidating, or adding a new practice location. IHS scopes each engagement after a free introductory call. See our DMEPOS Accreditation Cost Guide for full fee details.

Source: CMS — CMS fee page, read 2 October 2026. Verify current fees with CMS.

Source: ABC — ABC fee page, read 2 October 2026. Verify current fees with ABC.

What are the ongoing costs of maintaining DMEPOS accreditation under the new annual survey rule?

Before 2026, keeping accreditation meant roughly one survey project every three years. An annual survey cycle raises compliance operating costs.

What are the costs of non-compliance or losing DMEPOS accreditation?

Loss of accreditation stops Medicare DMEPOS billing until the supplier is accredited and enrolled again.

IHS scopes each engagement after a free introductory call; fees depend on scope.

What Can Go Wrong? Survey Deficiencies and Risks

Which DMEPOS survey deficiencies should suppliers prepare for?

Areas where DMEPOS surveys can cite deficiencies include:

1. Equipment Cleaning and Storage (ACHC DRX7-12D) — physical separation of clean and dirty equipment, transport infection control, warehouse sanitation
2. Safety Program Documentation — outdated oxygen storage, PPE, and fire safety policies (Source: CHAP 2025/2026)
3. TB Control Plans — missing personnel TB screening records per state and CDC guidelines (Source: CHAP 2025/2026)
4. Leadership Policy Review (TCT ADM 1.0) — no documented annual P&P review by organizational leadership (Source: TCT 2025/2026)
5. Ongoing HR Training (TCT HR 1.0) — missing annual FWA, HIPAA, and OSHA training logs (Source: TCT 2025/2026)
6. Patient Equipment Training — unsigned patient and caregiver equipment instruction forms (Source: CHAP 2025/2026)
7. Respiratory Setup Guidelines — misalignment with current AARC guidelines (Source: CHAP 2025/2026)
8. Patient File Credentialing — missing physician signatures, date stamps, or F2F encounter notes; 83 DMEPOS items now on CMS F2F/WOPD required prior authorization list as of April 13, 2026 (Source: CMS)
9. Complaint Log Management — no distinct accessible complaint log with documented resolution (Source: CMS)
10. Sanitary Environment — facility cleanliness failures in rehab modification areas or CPAP fitting rooms (Source: ACHC)

What happens to my Medicare billing if I lose DMEPOS accreditation?

Under 42 CFR 424.57(c)(22), every DMEPOS supplier location must meet the DMEPOS quality standards and be separately accredited to enroll in and bill Medicare, and CMS may deny or revoke the enrollment of a supplier that does not meet those standards (42 CFR 424.57, Cornell LII, page opened October 3, 2026). Because accreditation is a condition of enrolling in and billing Medicare, a lapse in accreditation puts a supplier's enrollment at risk.

What is the BOC/CMS lawsuit situation and how does it affect my accreditation choice?

In December 2025 BOC sued HHS, CMS and the HHS Secretary in federal court, seeking review of agency action and asking for a temporary restraining order (Board of Certification/Accreditation International, Inc. v. Kennedy, No. 1:25-cv-04150 (D. Md.), docket, page opened October 4, 2026). The public docket we reviewed does not show the case's current status. Check CMS's current list of approved DMEPOS accrediting organizations and BOC's status in your state before you choose BOC. A supplier that relies on BOC can follow the case and decide whether it wants a contingency plan for moving to another CMS-approved accrediting organization.

How does the 36-month ownership rule affect DMEPOS M&A transactions in 2026?

The 36-month rule, effective January 1, 2026 for DMEPOS suppliers under 42 CFR 424.551, requires a supplier that undergoes a change in majority ownership (more than a 50 percent direct ownership interest) within 36 months of its enrollment or its last change in majority ownership to be surveyed and accredited and to enroll as a new DMEPOS supplier, unless an exception in 424.551 applies (CMS DMEPOS Accreditation Guidance). For M&A buyers, this means: (1) verify whether the target triggered the 36-month window by its own enrollment or prior ownership change; (2) if a 36-month window is active, new enrollment is required — but the February 27, 2026 enrollment moratorium for DMEPOS medical supply companies (6-month duration) may prevent enrollment; (3) deal structures must account for billing interruption as a material risk factor. IHS provides M&A accreditation due diligence engagements specifically for the 36-month rule. (Sources: Hall Render; Benesch Law)

How Does DMEPOS Accreditation Compare to Alternatives?

ACHC vs. BOC vs. The Compliance Team — which DMEPOS accreditor should I choose?

The right choice depends on your product categories, state(s) of operation, and risk tolerance. ACHC: 2025/2026 standards updated August 29, 2025. TCT: real-time web portal simplifies documentation for annual survey readiness. BOC: check CMS's current list and BOC's status in your state, since BOC filed a federal lawsuit in December 2025. IHS provides independent accreditor selection guidance based solely on your situation. See our full ACHC vs. BOC vs. TCT Comparison page for the detailed side-by-side analysis.

How does DMEPOS accreditation differ from home health agency accreditation?

DMEPOS accreditation covers equipment and supply providers — organizations delivering products to patients. Home health agency (HHA) accreditation covers clinical care — organizations sending skilled clinicians into patients' homes. The standards frameworks, survey focus, and compliance requirements are fundamentally different, though several AOs (ACHC, CHAP, TJC) offer both. Some organizations need both — respiratory suppliers expanding into clinical services, or home infusion companies adding DMEPOS billing categories. IHS prepares organizations for both, in one engagement when both are needed. See our Home Health & Hospice Accreditation Consulting page.

Is DMEPOS accreditation recognized by Medicaid as well as Medicare?

DMEPOS accreditation is a federal Medicare requirement. Individual state Medicaid programs set their own billing requirements — some states accept federal DMEPOS accreditation as sufficient, others impose separate state licensure. Florida, Texas, California, and Illinois impose state-level requirements beyond federal accreditation regardless of Medicare status (see state-specific requirements on our service page). Medicaid managed care contracts may also impose accreditation requirements. IHS maps both federal and state Medicaid requirements in the same engagement.

Still Have Questions? Schedule a Consultation.

IHS provides independent, accreditor-neutral DMEPOS accreditation consulting. No financial relationship with any AO. No generic templates. Every engagement is built around your product mix, state exposure, and timeline.

Related pages: DMEPOS Accreditation Consulting Overview | ACHC vs. BOC vs. TCT Comparison | Cost Guide

Adjacent services: Home Health & Hospice Accreditation